The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemiaPatrick Williams, Naval Daver, Juliana Hidalgo Lopez et al.|Cancer|2018Cited by 339
Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasmsAdam S. Sperling, Koichi Takahashi, Veronica Guerra et al.|Blood|2022Cited by 138
Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortiumCristina Astrid Tentori, David A. Sallman, Lin P. Zhao et al.|HemaSphere|2024Cited by 11
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Takahashi, Koichi Saeki et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 6
Blinatumomab and ponatinib demonstrates ongoing efficacy as frontline therapy in Philadelphia positive B-cell acute lymphoblastic leukemia: Long-term follow-up from a phase 2 StudyHannah Goulart, Hagop Kantarjian, Elias Jabbour et al.|Blood|2025Cited by 2